- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 23.07. | Sona Nanotech Inc: Sona receives ethics board OK for THT pilot human study | 1 | Stockwatch | ||
| 23.07. | Sona Nanotech Inc.: Sona Announces Canadian Melanoma Clinical 'Pilot' Study Ethics Approval | 465 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - July 23, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona"), an oncology-focused life sciences company developing innovative therapies... ► Artikel lesen | |
| 08.07. | Sona Nanotech doses first patient in groundbreaking cancer therapy trial | 1 | The Market Herald Canada | ||
| 08.07. | Sona Nanotech Inc: Sona completes first dosing in early FS trial | 1 | Stockwatch | ||
| 07.07. | Sona Nanotech Inc.: First Patient Dosed in Early Feasibility Study Trial of its Cancer Therapy | 657 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - July 7, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") an oncology-focused life sciences company developing innovative therapies... ► Artikel lesen | |
| 27.06. | Sona Nanotech Inc: Sona receives committee approval for melanoma trial | 2 | Stockwatch | ||
| 27.06. | Sona Nanotech Inc.: Sona Announces Ethics Committee Approval For Melanoma Clinical Trial | 425 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - June 27, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona"), an oncology-focused life sciences company developing innovative therapies... ► Artikel lesen | |
| 17.06. | Sona Nanotech Inc: Sona to conduct FS trial for targeted hyperthermia | 7 | Stockwatch | ||
| SONA NANOTECH Aktie jetzt für 0€ handeln | |||||
| 16.06. | Sona Nanotech Inc.: Sona Engages Clinical Trial Clinic for First-in-Human Early Feasibility Study of its THT Cancer Therapy | 400 | Newsfile | First Patients Expected to be Enrolled This MonthHalifax, Nova Scotia--(Newsfile Corp. - June 16, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") an oncology-focused life... ► Artikel lesen | |
| 28.05. | Sona Nanotech Inc: Sona completes toxicity study on its gold nanorods | 14 | Stockwatch | ||
| 27.05. | Sona Nanotech Inc.: Sona Successfully Completes FDA-Required Toxicity Study | 537 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - May 27, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") is pleased to announce positive results from a required preclinical safety... ► Artikel lesen | |
| 16.05. | Sona Nanotech Inc: Sona completes bacterial endotoxin test on nanorods | 4 | Stockwatch | ||
| 15.05. | Sona Nanotech Inc.: Sona Announces Successful Study Showing Absence of Endotoxins In Its Cancer Therapy Gold Nanorods Prior to First-in-human Clinical Trial | 813 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - May 15, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") is pleased to announce the successful completion of bacterial endotoxin... ► Artikel lesen | |
| 07.05. | BioVaxys & Sona Nanotech Enter Research Collaboration | 3 | Contract Pharma | ||
| 07.05. | Sona Nanotech Inc.: BioVaxys and Sona Nanotech Enter Research Collaboration | 694 | Newsfile | Vancouver, British Columbia, and Halifax, Nova Scotia--(Newsfile Corp. - May 7, 2025) - BioVaxys Technology Corp. (CSE: BIOV) (FSE: 5LB) (OTCQB: BVAXF) ("BioVaxys") and Sona Nanotech Inc. (CSE: SONA)... ► Artikel lesen | |
| 07.05. | BioVaxys Technology Corp.: BioVaxys and Sona Nanotech Enter Research Collaboration | 880 | PR Newswire | VANCOUVER, BC and HALIFAX, NS, May 7, 2025 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys") and Sona Nanotech Inc.... ► Artikel lesen | |
| 01.05. | Sona Nanotech Inc: Sona Nanotech grants options to buy 2.13 million shares | 1 | Stockwatch | ||
| 01.05. | Sona Nanotech Inc.: Sona Nanotech Announces Annual Options Grants | 1.173 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - May 1, 2025) - Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the "Company" or "Sona") announces that it has granted 2,135,000 incentive stock options under... ► Artikel lesen | |
| 19.03. | Sona Nanotech Inc.: Sona Presents Additional Preclinical Data Demonstrating Repeated Ability Of Its Cancer Therapy To Inhibit Tumor Growth In Colorectal Cancer Model | 963 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - March 19, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") is pleased to provide updated data confirming efficacy of its Targeted... ► Artikel lesen | |
| 06.03. | Sona Nanotech Inc. CEO David Regan to Present at the Investor Summit Virtual on March 11 | 624 | ACCESS Newswire | NEW YORK, NY / ACCESS Newswire / March 6, 2025 / David Regan, CEO of Sona Nanotech Inc. (OTCQB:SNANF)(CSE:SONA), will be presenting at this year's Investor Summit Virtual on March 11th at 11:30am ET.About... ► Artikel lesen |
1 2 Weiter >>
28 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FORMYCON | 25,800 | +2,18 % | Formycon-Aktie gewinnt 2,76 Prozent (26,10 €) | Die Formycon-Aktie notiert heute ein wenig fester. Das Wertpapier kostete zuletzt 26,10 Euro. Ein Wertanstieg von 2,76 Prozent steht gegenwärtig für die Formycon-Aktie zu Buche. Das Papier verteuerte... ► Artikel lesen | |
| OBDUCAT | 0,024 | +9,09 % | XFRA CAPITAL ADJUSTMENT INFORMATION - 14.03.2025 | Das Instrument OBD SE0000514705 OBDUCAT AB B SK 8 EQUITY wird cum Kapitalmassnahme gehandelt am 14.03.2025 und ex Kapitalmassnahme am 17.03.2025 The instrument OBD SE0000514705 OBDUCAT AB B SK 8 EQUITY... ► Artikel lesen | |
| SOLESENCE | 3,350 | +8,06 % | Solésence, Inc.: Solésence Reports Second Quarter 2025 Financial Results | ROMEOVILLE, Ill., July 31, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced... ► Artikel lesen | |
| ONTO INNOVATION | 89,50 | +1,13 % | What Analysts Are Saying About Onto Innovation Stock | ||
| GOMSPACE | 1,000 | 0,00 % | GomSpace Group AB: GomSpace reports positive net profit in Q1 2025 | GomSpace releases its Q1 2025 trading statement and reports a strong revenue growth, positive operational EBITDA and a positive net profit in the first quarter.
FIRST QUARTER OF 2025
Order intake... ► Artikel lesen | |
| LAMPETIA | 0,116 | -3,33 % | EQS-News: LEHNER INVESTMENTS AG: Jahresabschluss 2024 mit positivem Ergebnis | EQS-News: LEHNER INVESTMENTS AG
/ Schlagwort(e): Jahresergebnis
LEHNER INVESTMENTS AG: Jahresabschluss 2024 mit positivem Ergebnis
30.06.2025 / 16:18 CET/CEST
Für den... ► Artikel lesen | |
| NANOFORM FINLAND | 0,978 | +2,19 % | Nanoform Finland Oyj: Nanoform starts Pivotal Human Bioequivalence Studies of Nanoenzalutamide | Nanoform Finland Plc | Press Release | June 12, 2025 at 08:10:00 EEST
HELSINKI, FINLAND, June 12, 2025 - Nanoform Finland Plc, the medicine performance-enhancing company, today announced that it had... ► Artikel lesen | |
| GAUZY | 6,260 | 0,00 % | Alejandro Weinstein rejoins Gauzy's board as company streamlines leadership | ||
| KOPIN | 1,668 | +0,85 % | KOPIN CORP - 8-K, Current Report | ||
| DOTZ NANO | 0,022 | -4,44 % | DOTZ NANO LIMITED: Application for quotation of securities - DTZ | ||
| VEECO INSTRUMENTS | 19,800 | -2,94 % | Veeco's Q2 revenue, operating income and EPS exceed guidance, but constrained by tariffs | ||
| NVE | 52,50 | -1,87 % | Dividendenbekanntmachungen (04.08.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AMERIPRISE FINANCIAL INC US03076C1062 1,6 USD 1,3806 EUR AMERISERV FINANCIAL INC US03074A1025 0,03 USD 0,0258 EUR ATLANTIC UNION... ► Artikel lesen | |
| FENDX TECHNOLOGIES | 0,035 | +7,93 % | FendX Technologies Inc.: FendX Provides Corporate Update | Vancouver, British Columbia--(Newsfile Corp. - July 18, 2025) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D) (the "Company" or "FendX"), an innovative surface protection company using... ► Artikel lesen | |
| NANOFOCUS | 1,120 | 0,00 % | NanoFocus: Hauptaktionär plant Squeeze-out | Die Carl Mahr Holding GmbH hat ein offizielles Verlangen auf Durchführung eines aktienrechtlichen Squeeze-outs bei der NanoFocus AG übermittelt. Demnach soll die Hauptversammlung einen Beschluss fassen... ► Artikel lesen | |
| ACACIA RESEARCH | 2,700 | 0,00 % | Acacia Research und Partner entwickeln eine mit Bitcoin gesicherte Gewerbedarlehensstrategie |
Das Unternehmen SONA NANOTECH INC kann der Branche Nanotechnologie zugeordnet werden.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SONA NANOTECH INC finden Sie auf Wallstreet Online.